| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/28/2001 | EP1077950A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments |
| 02/28/2001 | EP1077948A1 Novel 1,2,5-trisubstituted 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, method for the production and use thereof as a medicament |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077944A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077935A1 Phenylsulfonamide-phenylethylamines useful as dopamine receptors |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077928A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077927A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2001 | EP1077715A1 Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077706A1 Ionophore containing composition for modulating amyloidosis |
| 02/28/2001 | EP1077704A1 Combination therapy for treatment of depression |
| 02/28/2001 | EP1077702A1 Peripheral benzodiazepine receptor ligands |
| 02/28/2001 | EP1077692A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 02/28/2001 | EP1077690A1 Use of amyloid inhibitors for modulating neuronal cell death |
| 02/28/2001 | EP1077689A1 Acylpeptide protease inhibitors to enhance cognitive function |
| 02/28/2001 | EP1077688A1 Transdermal therapeutic system containing pergolide |
| 02/28/2001 | EP1077685A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077683A1 Antidepressant therapy |
| 02/28/2001 | EP1077682A2 Novel formulation containing paroxetine |
| 02/28/2001 | EP0792879B1 Process for preparing 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate |
| 02/28/2001 | CN1285844A Compound |
| 02/28/2001 | CN1285843A Compound |
| 02/28/2001 | CN1285842A Compound |
| 02/28/2001 | CN1285836A 3'-epimeric k-252a derivatives |
| 02/28/2001 | CN1285828A Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 02/28/2001 | CN1285823A Phenyl-alkyl-imidazoles as H3 receptor antagonists |
| 02/28/2001 | CN1285822A H receptor ligands of phenyl-alkyl-imidazoles type |
| 02/28/2001 | CN1285821A Aryl Fused azapolycyclic compounds |
| 02/28/2001 | CN1285820A Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 02/28/2001 | CN1285818A Compound for antemortem diagnosis of alzheimer's disease and i(IN VIVO) imaging and prevention of amyloid deposition |
| 02/28/2001 | CN1285817A Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same |
| 02/28/2001 | CN1285742A Combination of active principles for treating senile dementia such as alzheimer dementia |
| 02/28/2001 | CN1285356A Depeptide compound, its medical salt or ester, the medicinal composition using same as active component and the application for treating and preventing cell from dying |
| 02/28/2001 | CN1285220A Powder medicine made of Chinese and Western medicines for treating toothache and preparation process thereof |
| 02/28/2001 | CN1285216A Shencaosanye tea |
| 02/28/2001 | CN1285214A Traditional Chinese medicine for treating headache |
| 02/28/2001 | CN1285190A Application of isogorgonian acid in pharmacy |
| 02/28/2001 | CN1285189A Fluoxetine enteric soluble micro-capsule |
| 02/28/2001 | CN1062552C Cyclohexadiene derivatives, pharmaceuticals contg. same, prepn. method and use thereof |
| 02/28/2001 | CN1062477C Traditional Chinese medicine for treating vegetative nerve functional disturbance |
| 02/27/2001 | US6194574 Selectively bind to corticotropin-releasing factor (crf1) receptors; for treating stress related disorders such as post traumatic stress disorder (ptsd) as well as depression, headache and anxiety |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194449 Allosteric adenosine receptor modulators |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194437 Non-peptide bombesin receptor antagonists |
| 02/27/2001 | US6194428 Use of 5-substituted pyridine and hexahydroquinoline-3 carboxylic acid derivatives for treating diseases of the central nervous system |
| 02/27/2001 | US6194427 Brain disorders; psychological disorders; sleep disorders; anticonvulsants |
| 02/27/2001 | US6194423 Fused isoquinolines as dopamine receptor ligands |
| 02/27/2001 | US6194422 Antibiotic; amyloidoses therapy |
| 02/27/2001 | US6194416 Central nervous system disorders; alzheimer's disease |
| 02/27/2001 | US6194410 Antiserotonine agents; nervous system and psychological disorders |
| 02/27/2001 | US6194408 Parasiticides |
| 02/27/2001 | US6194405 3,3a,8,12b-tetrahydro-n-methyl-2h-dibenzo(3,4:6,7)-cyclohepta( 1,2-b)-furan-2-methanamine, for example; anxiolytic agents, antidepressants, sleep and sexual disorders, psychological, cardiovascular and gastrointestinal disorders |
| 02/27/2001 | US6194404 Process for the isolation of galanthamine |
| 02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
| 02/27/2001 | US6194171 Also vectors, transformed cells; useful for expression in cells for the purposes of identifying agonists or antagonists of ataxin-2-binding protein function |
| 02/27/2001 | US6194153 Methods for determining risk of developing alzheimer's disease by detecting mutations in the presenilin 1 (PS-1) gene |
| 02/27/2001 | US6194004 Dry mix formulation for bisphosphonic acids |
| 02/27/2001 | US6193993 Suppository containing an antidementia medicament |
| 02/27/2001 | US6193965 Administering therapeutically effective amount of reagent which modulates kinase activity for treating cell proliferative disorder associated with c-jun n-terminal kinase disorder, |
| 02/27/2001 | US6193962 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| 02/27/2001 | CA2317064A1 Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal |
| 02/27/2001 | CA2317053A1 New pyridine derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 02/27/2001 | CA2316662A1 Use of crf antagonists and related compositions |
| 02/27/2001 | CA2232789C Method for treating alzheimer's disease using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 02/27/2001 | CA2194370C Attenuation of wound healing processes |
| 02/27/2001 | CA2124206C Indole derivatives |
| 02/27/2001 | CA2111204C Piperidine derivatives having anxiolytic effect |
| 02/22/2001 | WO2001013108A1 Method for identifying modulating compounds of neurotransmitters |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012673A1 Pgpcr-3 polypeptides and dna sequences thereof |
| 02/22/2001 | WO2001012671A1 Human tumor necrosis factor receptor tr16 |
| 02/22/2001 | WO2001012670A1 Tgf-beta receptor polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012662A2 Membrane associated proteins |
| 02/22/2001 | WO2001012654A2 Orally active peptides that prevent cell damage and death |
| 02/22/2001 | WO2001012630A1 Spirocyclic ligands for sigma receptors, and libraries and methods of use thereof |
| 02/22/2001 | WO2001012629A1 Azaindoles having serotonin receptor affinity |
| 02/22/2001 | WO2001012628A1 Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation |
| 02/22/2001 | WO2001012627A1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 02/22/2001 | WO2001012624A1 Paroxetine |
| 02/22/2001 | WO2001012623A1 Process for the preparation of paroxetine hydrochloride |
| 02/22/2001 | WO2001012622A1 Piperidine and pyrrolidine derivatives displaying neuronal activity |
| 02/22/2001 | WO2001012621A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 02/22/2001 | WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | WO2001012606A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 02/22/2001 | WO2001012603A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | WO2001012602A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012596A1 Prostaglandin derivatives |
| 02/22/2001 | WO2001012592A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | WO2001012584A2 Pharmaceutical compounds |
| 02/22/2001 | WO2001012265A1 Use of cyamemazine for cold turkey benzodiazepine treatment |
| 02/22/2001 | WO2001012236A2 Methods, compositions and kits for promoting recovery from damage to the central nervous system |